Genetic Technologies Ltd Total Liabilities
Genetic Technologies Ltd total liabilities. Based on the latest financial reports, Genetic Technologies Ltd (GTG) has total liabilities worth AU$3.92 Million AUD (≈ $2.77 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GTG cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Genetic Technologies Ltd (2000–2024)
Total liabilities of Genetic Technologies Ltd from 2000 to 2024. This chart illustrates how Genetic Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data.
Genetic Technologies Ltd Competitors by Total Liabilities
The table below lists competitors of Genetic Technologies Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sonim Technologies Inc
NASDAQ:SONM
|
USA | $5.75 Million |
|
International Biotechnology Trust plc
LSE:IBT
|
UK | GBX34.63 Million |
|
OMG Group Ltd
AU:OMG
|
Australia | AU$3.08 Million |
|
SIXTY SIX CAPITAL INC.
F:5CR0
|
Germany | €3.04 Million |
|
Entreprendre
PA:ALENR
|
France | €4.75 Million |
|
Baillie Gifford Shin Nippon PLC
LSE:BGS
|
UK | GBX53.58 Million |
|
Winshear Gold Corp
V:WINS
|
Canada | CA$184.29K |
|
RUBIX Resources Ltd
AU:RB6
|
Australia | AU$204.68K |
Liability Composition Analysis (2000–2024)
This chart breaks down Genetic Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see GTG total assets.
Liquidity & Leverage Metrics
Genetic Technologies Ltd Total Liabilities Ratios Explained
Genetic Technologies Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genetic Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genetic Technologies Ltd (2000–2024)
The table below shows the annual total liabilities of Genetic Technologies Ltd from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | AU$4.36 Million ≈ $3.08 Million |
+17.93% |
| 2023-06-30 | AU$3.69 Million ≈ $2.61 Million |
-15.49% |
| 2022-06-30 | AU$4.37 Million ≈ $3.09 Million |
+203.80% |
| 2021-06-30 | AU$1.44 Million ≈ $1.02 Million |
-12.30% |
| 2020-06-30 | AU$1.64 Million ≈ $1.16 Million |
+9.81% |
| 2019-06-30 | AU$1.49 Million ≈ $1.06 Million |
+2.73% |
| 2018-06-30 | AU$1.45 Million ≈ $1.03 Million |
-4.91% |
| 2017-06-30 | AU$1.53 Million ≈ $1.08 Million |
+8.73% |
| 2016-06-30 | AU$1.41 Million ≈ $995.19K |
-20.11% |
| 2015-06-30 | AU$1.76 Million ≈ $1.25 Million |
-64.08% |
| 2014-06-30 | AU$4.90 Million ≈ $3.47 Million |
+91.38% |
| 2013-06-30 | AU$2.56 Million ≈ $1.81 Million |
+25.61% |
| 2012-06-30 | AU$2.04 Million ≈ $1.44 Million |
-3.28% |
| 2011-06-30 | AU$2.11 Million ≈ $1.49 Million |
-17.70% |
| 2010-06-30 | AU$2.56 Million ≈ $1.81 Million |
-46.51% |
| 2009-06-30 | AU$4.79 Million ≈ $3.39 Million |
+44.42% |
| 2008-06-30 | AU$3.32 Million ≈ $2.35 Million |
-18.12% |
| 2007-06-30 | AU$4.05 Million ≈ $2.87 Million |
-3.01% |
| 2006-06-30 | AU$4.18 Million ≈ $2.95 Million |
-35.85% |
| 2005-06-30 | AU$6.51 Million ≈ $4.61 Million |
+22.35% |
| 2004-06-30 | AU$5.32 Million ≈ $3.76 Million |
+79.25% |
| 2003-06-30 | AU$2.97 Million ≈ $2.10 Million |
+59.17% |
| 2002-06-30 | AU$1.86 Million ≈ $1.32 Million |
+15.24% |
| 2001-06-30 | AU$1.62 Million ≈ $1.14 Million |
+27.42% |
| 2000-06-30 | AU$1.27 Million ≈ $898.53K |
-- |
About Genetic Technologies Ltd
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinicall… Read more